跳至主要内容
临床试验/NCT00279968
NCT00279968已完成不适用

Investigating Significant ICD Heart Therapies Registry Study (INSIGHTS ICD Registry)

Medtronic Cardiac Rhythm and Heart Failure0 个研究点目标入组 1,326 人开始时间: 2004年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,326

研究概览

简要总结

The purpose of the Registry is to collect data on how Implantable Cardioverter Defibrillator (ICD) therapies and medications are being used by physicians to treat ventricular arrhythmias in order to better understand how to improve the clinical care of patients and effectiveness of ICD therapies.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients 18 years of age or older.
  • Patients or legal guardians who are willing and able to sign a Permission for Access to and Use of Health Information in a Registry Form and, if required by an Institution's IRB, an Informed Consent.
  • New or replacement implants of Medtronic market released single, dual or triple chamber ICDs including: GEM VR, GEM DR, GEM III AT, Marquis VR, Marquis DR, Maximo DR, Maximo VR, InSync ICD, InSync Marquis ICD and InSync II Marquis ICD.

排除标准

  • Patients enrolled in a device study which effects programming and or treatment.

研究者

发起方
Medtronic Cardiac Rhythm and Heart Failure
申办方类型
Industry

相似试验